Skip to content

Apotheek Simons: what changed

BE 0558.895.192NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€119,604
2024 · €115,720+€3,884
Equity
€164,530
2024 · €164,530
Cash
€106,576
2024 · €79,885+€26,691
Balance sheet total
€646,845
2024 · €671,251-€24,407

Largest movements

2024 to 2025
Assets
  • Cash +€26,691

    up €26,691 (+33.4%), from €79,885 to €106,576

    mainly Net result for the year (+€119,604) and Current investments (+€23,107)

  • Current investments -€23,107

    down €23,107 (-20.9%), from €110,590 to €87,483

  • Tangible fixed assets -€21,116

    down €21,116 (-8.5%), from €249,883 to €228,767

    of which Land and buildings: -€19,800

  • Receivables within one year -€21,080

    down €21,080 (-19.3%), from €109,397 to €88,317

    of which Trade receivables: -€21,553

  • Stocks and contracts +€13,752

    up €13,752 (+13.0%), from €105,550 to €119,302

Equity and liabilities
  • Debts after one year -€23,308

    down €23,308 (-10.0%), from €232,485 to €209,177

  • Accrued charges and deferred income -€6,801

    down €6,801 (-84.9%), from €8,009 to €1,208

Income statement
  • Depreciation -€17,974

    down €17,974 (-45.2%), from €39,740 to €21,766

  • Financial charges -€10,922

    down €10,922 (-26.7%), from €40,913 to €29,991

  • Financial income -€10,057

    down €10,057 (-75.9%), from €13,244 to €3,187

  • Gross operating margin -€9,736

    down €9,736 (-3.3%), from €294,963 to €285,227

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €115,720
Gross operating margin -€9,736
Staff costs -€2,866
Depreciation +€17,974
Other operating charges +€52
Financial income -€10,057
Financial charges +€10,922
Taxes -€2,404
Result 2025 €119,604
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€146,450
Investment +€22,457
Financing -€142,217
Cash 2024 €79,885
Net result for the year +€119,604
Depreciation +€21,766
Stocks and contracts -€13,752
Receivables within one year +€21,080
Deferred charges and accrued income -€454
Trade debts +€840
Tax, wage and social debts +€649
Other debts +€3,518
Accrued charges and deferred income -€6,801
Investment in fixed assets (net) -€650
Current investments +€23,107
Debts after one year -€23,308
Current portion of long-term debt +€695
Contributions, distributions and other -€119,604
Cash 2025 €106,576
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €671,251 €646,845 -€24,407 -3.6%
Fixed assets 21/28 €249,883 €228,767 -€21,116 -8.5%
Tangible fixed assets 22/27 €249,883 €228,767 -€21,116 -8.5%
Land and buildings 22 €244,026 €224,226 -€19,800 -8.1%
Plant, machinery and equipment 23 €2,209 €1,857 -€352 -15.9%
Furniture and vehicles 24 €3,648 €2,685 -€964 -26.4%
Current assets 29/58 €421,369 €418,078 -€3,291 -0.8%
Stocks and contracts in progress 3 €105,550 €119,302 +€13,752 +13.0%
Stocks 30/36 €105,550 €119,302 +€13,752 +13.0%
Amounts receivable within one year 40/41 €109,397 €88,317 -€21,080 -19.3%
Trade receivables 40 €107,231 €85,678 -€21,553 -20.1%
Other amounts receivable 41 €2,166 €2,639 +€473 +21.9%
Current investments 50/53 €110,590 €87,483 -€23,107 -20.9%
Cash at bank and in hand 54/58 €79,885 €106,576 +€26,691 +33.4%
Deferred charges and accrued income 490/1 €15,947 €16,400 +€454 +2.8%
Total equity and liabilities 10/49 €671,251 €646,845 -€24,407 -3.6%
Equity 10/15 €164,530 €164,530 = 0.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €145,930 €145,930 = 0.0%
Distributable reserves 133 €145,930 €145,930 = 0.0%
Provisions and deferred taxes 16 €18,000 €18,000 = 0.0%
Provisions for liabilities and charges 160/5 €18,000 €18,000 = 0.0%
Major repairs and maintenance 162 €18,000 €18,000 = 0.0%
Amounts payable 17/49 €488,722 €464,315 -€24,407 -5.0%
Amounts payable after more than one year 17 €232,485 €209,177 -€23,308 -10.0%
Financial debts 170/4 €232,485 €209,177 -€23,308 -10.0%
Amounts payable within one year 42/48 €248,228 €253,930 +€5,702 +2.3%
Current portion of amounts payable after more than one year 42 €22,613 €23,308 +€695 +3.1%
Trade debts 44 €51,889 €52,729 +€840 +1.6%
Suppliers 440/4 €51,889 €52,729 +€840 +1.6%
Taxes, remuneration and social security 45 €10,194 €10,843 +€649 +6.4%
Taxes 450/3 €1,006 €1,379 +€373 +37.0%
Remuneration and social security 454/9 €9,188 €9,464 +€277 +3.0%
Other amounts payable 47/48 €163,532 €167,050 +€3,518 +2.2%
Accrued charges and deferred income 492/3 €8,009 €1,208 -€6,801 -84.9%
Remuneration, social security and pensions 62 €78,193 €81,059 +€2,866 +3.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €39,740 €21,766 -€17,974 -45.2%
Other operating charges 640/8 €1,264 €1,212 -€52 -4.1%
Gross operating margin 9900 €294,963 €285,227 -€9,736 -3.3%
Operating profit (loss) 9901 €175,767 €181,190 +€5,423 +3.1%
Financial income 75/76B €13,244 €3,187 -€10,057 -75.9%
Recurring financial income 75 €13,244 €3,187 -€10,057 -75.9%
Financial charges 65/66B €40,913 €29,991 -€10,922 -26.7%
Recurring financial charges 65 €40,913 €29,991 -€10,922 -26.7%
Profit (loss) for the period before taxes 9903 €148,098 €154,386 +€6,289 +4.2%
Income taxes 67/77 €32,378 €34,782 +€2,404 +7.4%
Profit (loss) for the period 9904 €115,720 €119,604 +€3,884 +3.4%
Profit (loss) for the period to be appropriated 9905 €115,720 €119,604 +€3,884 +3.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€523,968 to €700,650

Midpoint €597,586 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €164,530
Capitalised earnings €883,407 to €1.2m
Indication €523,968 to €700,650

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€164,530
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€164,530

Capitalised earnings

net result for the year (9904)
2025
€119,604
2024
€115,720
2023
€131,400
excluding non-recurring income and charges
€135,706
2022
€147,485
2021
€88,271
Average result, excluding non-recurring income and charges
€123,677
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€883,407 / €1.0m / €1.2m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 10 November 2026 via checked.be.